1. Home
  2. KW vs RLAY Comparison

KW vs RLAY Comparison

Compare KW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kennedy-Wilson Holdings Inc.

KW

Kennedy-Wilson Holdings Inc.

HOLD

Current Price

$9.84

Market Cap

1.4B

Sector

Finance

ML Signal

HOLD

Logo Relay Therapeutics Inc.

RLAY

Relay Therapeutics Inc.

HOLD

Current Price

$7.48

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KW
RLAY
Founded
1977
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
1992
2020

Fundamental Metrics

Financial Performance
Metric
KW
RLAY
Price
$9.84
$7.48
Analyst Decision
Sell
Strong Buy
Analyst Count
1
7
Target Price
$11.00
$16.00
AVG Volume (30 Days)
712.1K
2.0M
Earning Date
02-25-2026
02-25-2026
Dividend Yield
4.90%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$550,500,000.00
$8,355,000.00
Revenue This Year
N/A
$19.96
Revenue Next Year
$158.40
N/A
P/E Ratio
N/A
N/A
Revenue Growth
13.93
N/A
52 Week Low
$5.98
$1.78
52 Week High
$10.11
$9.04

Technical Indicators

Market Signals
Indicator
KW
RLAY
Relative Strength Index (RSI) 52.24 44.44
Support Level $9.71 $7.36
Resistance Level $10.09 $7.91
Average True Range (ATR) 0.18 0.46
MACD -0.02 -0.08
Stochastic Oscillator 51.00 32.42

Price Performance

Historical Comparison
KW
RLAY

About KW Kennedy-Wilson Holdings Inc.

Kennedy-Wilson Holdings Inc is a real estate investment company that owns, operates, and invests in real estate both on its own and through its investment management platform. The Company focuses on multifamily and office properties, as well as industrial and debt investments. It has two business segments; the Consolidated Portfolio includes investment activities that involve ownership of multifamily units, office, retail and industrial space, and one hotel, and The Co-Investment Portfolio segment consists of investments the Company makes with partners in which it receives fees, performance allocations that it earns on its fee-bearing capital and distributions and profits from its ownership interest in the underlying operations of its co-investments.

About RLAY Relay Therapeutics Inc.

Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).

Share on Social Networks: